HIGHLIGHTS
- who: Ming Gao and collaborators from the State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China have published the Article: Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE-/- Mice, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of /2022/
- what: The aim of this study -/-) mice is a classic model for atherosclerosis research . The aim of this study is (ApoE is to explore the anti-atherosclerosis effect of GPE on the inflammation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.